Immunotherapy Subcommittee

Purpose

The Immunotherapy subcommittee evaluates NRG concepts that utilize immunotherapy for feasibility, safety, and potential translational objectives. Furthermore, the Immunotherapy subcommittee in conjunction with disease sites may propose concepts involving immunotherapy. This committee meets quarterly.

Scientific Program

Scientific Program Scientific Core Committees Medical Oncology Committee Immunotherapy Subcommittee

Immunotherapy Subcommittee Leadership

Chair

Susanna Ulahannan, MD

Vice Chair

Janice Lu, MD, PhD
Core Committee Members
  • Amma Agyemang
  • Mariam AlHilli
  • Adanma Anji Ayanambakkam Attanathi
  • Harry D. Bear
  • Julia B. Blanter
  • Leslie Bradford
  • Laura Chambers
  • Eileen Connolly
  • Jennifer F. De Los Santos
  • Tarik Demir
  • Mahua Dey
  • Maria Diab
  • Claire F. Friedman
  • Eugenia Girda
  • Oleg Gligich
  • Daniel Haldar
  • Jessica Jou
  • Hyunseok Kang
  • Juraj Kavecansky
  • Namita Khanna
  • Sarah H. Kim
  • Eric C. Ko
  • Olivia Lara
  • Meredith LaRose
  • Lauren Lukas
  • Ariel E. Marciscano
  • Jyoti Mayadev
  • Diana Miao
  • Mitchell A. Mosley
  • Yvonne M. Mowery
  • Rebecca L. Porter
  • Tarik Silk
  • Travis T. Sims
  • Anna Spreafico
  • Kristen D. Starbuck
  • Gong Tang
  • Rachael B. Turner
  • Joan R. Tymon-Rosario
  • Susanna Ulahannan
  • Matthew K. Wagar
  • John L. Wagner
  • Meng Welliver
  • Trisha Wise-Draper
  • Joseph Zenga
  • Zhen Ni Zhou

 

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.